Medigene AG (XTER:MDG1) Days Sales Outstanding : 53.80 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Medigene AG Days Sales Outstanding?

Medigene AG's average Accounts Receivable for the six months ended in Dec. 2023 was €0.88 Mil. Medigene AG's Revenue for the six months ended in Dec. 2023 was €2.97 Mil. Hence, Medigene AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 53.80.

The historical rank and industry rank for Medigene AG's Days Sales Outstanding or its related term are showing as below:

XTER:MDG1' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.56 Med: 38.64 Max: 110.58
Current: 100.64

During the past 13 years, Medigene AG's highest Days Sales Outstanding was 110.58. The lowest was 21.56. And the median was 38.64.

XTER:MDG1's Days Sales Outstanding is ranked worse than
66.14% of 889 companies
in the Biotechnology industry
Industry Median: 71.03 vs XTER:MDG1: 100.64

Medigene AG's Days Sales Outstanding declined from Dec. 2022 (66.03) to Dec. 2023 (53.80).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Medigene AG Days Sales Outstanding Historical Data

The historical data trend for Medigene AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Days Sales Outstanding Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

21.56

30.47

33.25

24.99

110.58

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															29.47	7.63	66.03	136.25	53.80

Competitive Comparison of Medigene AG's Days Sales Outstanding

For the Biotechnology subindustry, Medigene AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medigene AG's Days Sales Outstanding falls into.

Medigene AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medigene AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.24	+	0.416)	/	2 )	/	6.034	*	365
=	1.828					/	6.034	*	365
=	110.58

Medigene AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.335	+	0.416)	/	2 )	/	2.97	*	365 / 2
=	0.8755					/	2.97	*	365 / 2
=	53.80

Medigene AG (XTER:MDG1) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medigene AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medigene AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (XTER:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (XTER:MDG1) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Austria

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (XTER:MDG1) Headlines

No Headlines